{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:42:00Z","timestamp":1791200520402,"version":"4.2.0"},"reference-count":104,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T00:00:00Z","timestamp":1361491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0056916","type":"journal-article","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T09:40:19Z","timestamp":1361612419000},"page":"e56916","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":71,"title":["Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of Plasmodium falciparum Malaria: A Systematic Review"],"prefix":"10.1371","volume":"8","author":[{"given":"Christine","family":"Manyando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Njunju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Van geertruyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,22]]},"reference":[{"key":"ref1","unstructured":"WHO (2012) World Malaria Report."},{"key":"ref2","unstructured":"WHO (2010) World Malaria report: Summary."},{"key":"ref3","unstructured":"WHO (2010) Guidelines for the Treatment of Malaria."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.2001.64.28","article-title":"The burden of malaria in pregnancy in malaria-endemic areas","volume":"64","author":"RW Steketee","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Van geertruyden JP, Thomas F, Erhart A, D&apos;Alessandro U (2004) The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 71: 35\u201340. 71\/2_suppl\/35 [pii].","DOI":"10.4269\/ajtmh.2004.71.35"},{"key":"ref6","first-page":"95","article-title":"Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: II: effects of placental malaria on perinatal outcome; malaria and HIV","volume":"80","author":"CJ Uneke","year":"2007","journal-title":"Yale J Biol Med"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Flateau C, Le LG, Pialoux G (2011) Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Lancet Infect Dis 11: 541\u2013556. S1473-3099(11)70031-7 [pii];10.1016\/S1473-3099(11)70031-7 [doi].","DOI":"10.1016\/S1473-3099(11)70031-7"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Briand V, Badaut C, Cot M (2009) Placental malaria, maternal HIV infection and infant morbidity. Ann Trop Paediatr 29: 71\u201383. 10.1179\/146532809X440699 [doi].","DOI":"10.1179\/146532809X440699"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"ter Kuile FO, van Eijk AM, Filler SJ (2007) Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 297: 2603\u20132616. 297\/23\/2603 [pii];10.1001\/jama.297.23.2603 [doi].","DOI":"10.1001\/jama.297.23.2603"},{"key":"ref10","unstructured":"WHO (2012) Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP)."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1371\/journal.pone.0005138","article-title":"Randomized trial of artesunate plus amodiaquine, sulfadoxine-pyrimethamine plus amodiaquine, chlorproguanil-dapsone and SP for malaria in Pregnancy in Tanzania","volume":"4","author":"TK Mutabingwa","year":"2009","journal-title":"PLos one"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Van geertruyden JP, Menten J, Colebunders R, Korenromp E, D&apos;Alessandro U (2008) The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance. Malar J 7: 134. 1475-2875-7-134 [pii];10.1186\/1475-2875-7-134 [doi].","DOI":"10.1186\/1475-2875-7-134"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3201\/eid1109.050337","article-title":"Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa","volume":"11","author":"EL Korenromp","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ladner J, Leroy V, Karita E, van de Perre P, Dabis F (2003) Malaria, HIV and pregnancy. AIDS 17: 275\u2013276. 10.1097\/01.aids.0000050793.28043.8b [doi].","DOI":"10.1097\/00002030-200301240-00025"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Gallagher M, Malhotra I, Mungai PL, Wamachi AN, Kioko JM, <etal>et al<\/etal>.. (2005) The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 19: 1849\u20131855. 00002030-200511040-00014 [pii].","DOI":"10.1097\/01.aids.0000189846.90946.5d"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4269\/ajtmh.2001.65.623","article-title":"Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya","volume":"65","author":"AM van Eijk","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ayisi JG, van Eijk AM, ter Kuile FO, Kolczak MS, Otieno JA, <etal>et al<\/etal>.. (2003) The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya. AIDS 17: 585\u2013594. 10.1097\/01.aids.0000042977.95433.37 [doi].","DOI":"10.1097\/00002030-200303070-00014"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"van Eijk AM, Ayisi JG, ter Kuile FO, Misore AO, Otieno JA, <etal>et al<\/etal>.. (2003) HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS 17: 595\u2013603. 10.1097\/01.aids.0000042975.95433.a5 [doi].","DOI":"10.1097\/00002030-200303070-00015"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00126334-200311010-00005","article-title":"Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe","volume":"34","author":"C Ticconi","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, <etal>et al<\/etal>.. (2004) The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 71: 41\u201354. 71\/2_suppl\/41 [pii].","DOI":"10.4269\/ajtmh.2004.71.41"},{"key":"ref21","unstructured":"WHO (2006) Guidelines on Cotrimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: Recommendations for a public health approach."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Lutalo T, <etal>et al<\/etal>.. (2006) Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 41: 504\u2013508. 10.1097\/01.qai.0000188122.15493.0a [doi];00126334-200604010-00015 [pii].","DOI":"10.1097\/01.qai.0000188122.15493.0a"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Crampin AC, Floyd S, Glynn JR, Madise N, Nyondo A, <etal>et al<\/etal>.. (2003) The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural Malawi. AIDS 17: 389\u2013397. 10.1097\/01.aids.0000042939.55529.a8 [doi].","DOI":"10.1097\/00002030-200302140-00013"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, <etal>et al<\/etal>.. (2005) Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 41: 1654\u20131661. CID37328 [pii];10.1086\/498029 [doi].","DOI":"10.1086\/498029"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, <etal>et al<\/etal>.. (2007) Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS 21: 2059\u20132066. 10.1097\/QAD.0b013e3282ef6da1 [doi];00002030-200710010-00008 [pii].","DOI":"10.1097\/QAD.0b013e3282ef6da1"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1476-5381.1968.tb00475.x","article-title":"Trimethoprim, a sulphonamide potentiator","volume":"33","author":"SR Bushby","year":"1968","journal-title":"Br J Pharmacol Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/jcp.21.2.202","article-title":"Trimethoprim: laboratory and clinical studies","volume":"21","author":"JH Darrell","year":"1968","journal-title":"J Clin Pathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.1.5643.541","article-title":"Trimethoprim\u2013sulphamethoxazole: comparative study in urinary infection in hospital","volume":"1","author":"DS Reeves","year":"1969","journal-title":"Br Med J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/00034983.1971.11686737","article-title":"Trimethoprim plus sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African schoolchildren","volume":"65","author":"PO Fasan","year":"1971","journal-title":"Ann Trop Med Parasitol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0035-9203(73)90340-4","article-title":"Letter: Effect of sulphamethoxazole-trimethoprim on the viability of Plasmodium falciparum gametocytes","volume":"67","author":"RN Wilkinson","year":"1973","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"von SL, Jawara M, Coleman R, Doherty T, Walraven G, <etal>et al<\/etal>.. (2001) Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine\/sulfadoxine, and pyrimethamine\/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health 6: 92\u201398. tmi683 [pii].","DOI":"10.1046\/j.1365-3156.2001.00683.x"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.2002.67.17","article-title":"Schellenberg D, Kahigwa E, Drakeley C, Malende A, Wigayi J, et al.2002) The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria","volume":"67","journal-title":"Am J Trop Med Hyg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/aje\/kwf030","article-title":"Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria","volume":"156","author":"F Mendez","year":"2002","journal-title":"Am J Epidemiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2000.62.210","article-title":"Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine","volume":"62","author":"V Robert","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4269\/ajtmh.2000.63.199","article-title":"Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania","volume":"63","author":"NI Akim","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Kone A, Siebelink-Stoter R, van Gemert GJ, Dara A, Niangaly H, <etal>et al<\/etal>.. (2010) Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Int J Parasitol 40: 1221\u20131228. S0020-7519(10)00185-2 [pii];10.1016\/j.ijpara.2010.05.004 [doi].","DOI":"10.1016\/j.ijpara.2010.05.004"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Hamel MJ, Holtz T, Mkandala C, Kaimila N, Chizani N, <etal>et al<\/etal>.. (2005) Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia. Am J Trop Med Hyg 73: 609\u2013615. 73\/3\/609 [pii].","DOI":"10.4269\/ajtmh.2005.73.609"},{"key":"ref38","first-page":"290","article-title":"Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection","volume":"82","author":"CJ Gill","year":"2004","journal-title":"Bull World Health Organ"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Lynen L, Jacobs J, Colebunders R (2007) Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough? Trans R Soc Trop Med Hyg 101: 1059\u20131060. S0035-9203(07)00207-6 [pii];10.1016\/j.trstmh.2007.07.001 [doi].","DOI":"10.1016\/j.trstmh.2007.07.001"},{"key":"ref40","first-page":"512","article-title":"An evaluation of co-trimoxazole in the treatment of Plasmodium falciparum malaria","volume":"61","author":"CF Hansford","year":"1982","journal-title":"S Afr Med J"},{"key":"ref41","first-page":"476","article-title":"Chemotherapeutic efficacy of cotrimoxazole for childhood malaria in an area of multidrug resistance in Tanzania","volume":"90","author":"TK Mutabingwa","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0035-9203(91)90285-7","article-title":"Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole","volume":"85","author":"OO Daramola","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0035-9203(98)90748-9","article-title":"Resistance in vivo of Plasmodium falciparum to co-trimoxazole in western Uganda","volume":"92","author":"AH Kilian","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Bamgboye AE, <etal>et al<\/etal>.. (2005) Effects of antifolates\u2013co-trimoxazole and pyrimethamine-sulfadoxine\u2013on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 100: 451\u2013455. S0074-02762005000400019 [pii];\/S0074-02762005000400019 [doi].","DOI":"10.1590\/S0074-02762005000400019"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0035-9203(01)90107-5","article-title":"Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children","volume":"95","author":"SA Omar","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Sowunmi A, Gbotosho GO, Fateye BA, Adedeji AA (2006) Predictors of the failure of treatment with trimethoprim-sulfamethoxazole in children with uncomplicated, Plasmodium falciparum malaria. Ann Trop Med Parasitol 100: 205\u2013211. 10.1179\/136485906X91503 [doi].","DOI":"10.1179\/136485906X91503"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, <etal>et al<\/etal>.. (2006) Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 367: 1256\u20131261. S0140-6736(06)68541-3 [pii];10.1016\/S0140-6736(06)68541-3 [doi].","DOI":"10.1016\/S0140-6736(06)68541-3"},{"key":"ref48","unstructured":"Byakika-Kibwika P, Ddumba E, Kamya M (2007) Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients. Afr Health Sci 7: 86\u201392. 10.5555\/afhs.2007.7.2.86 [doi]."},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Mermin J, Lule JR, Ekwaru JP (2006) Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr 41: 129\u2013130. 00126334-200601010-00023 [pii].","DOI":"10.1097\/01.qai.0000179427.11789.a7"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Anglaret X, Eholie S (2010) Co-trimoxazole, cART, and non-AIDS infectious diseases. Lancet 375: 1231\u20131233. S0140-6736(10)60200-0 [pii];10.1016\/S0140-6736(10)60200-0 [doi].","DOI":"10.1016\/S0140-6736(10)60200-0"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Corbett EL, Churchyard GJ, Charalambos S, Samb B, Moloi V, <etal>et al<\/etal>.. (2002) Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis 34: 1251\u20131258. CID011234 [pii];10.1086\/339540 [doi].","DOI":"10.1086\/339540"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0140-6736(96)90076-8","article-title":"Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya","volume":"347","author":"CF Gilks","year":"1996","journal-title":"Lancet"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, <etal>et al<\/etal>.. (1995) Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 333: 845\u2013851. 10.1056\/NEJM199509283331305 [doi].","DOI":"10.1056\/NEJM199509283331305"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, <etal>et al<\/etal>.. (2000) Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356: 1051\u20131056. S0140-6736(00)02727-6 [pii];10.1016\/S0140-6736(00)02727-6 [doi].","DOI":"10.1016\/S0140-6736(00)02727-6"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Walker AS, Ford D, Gilks CF, Munderi P, Ssali F, <etal>et al<\/etal>.. (2010) Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort. Lancet 375: 1278\u20131286. S0140-6736(10)60057-8 [pii];10.1016\/S0140-6736(10)60057-8 [doi].","DOI":"10.1016\/S0140-6736(10)60057-8"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Nakanjako D, Kiragga AN, Castelnuovo B, Kyabayinze DJ, Kamya MR (2011) Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda. Malar J 10: 66. 1475-2875-10-66 [pii];10.1186\/1475-2875-10-66 [doi].","DOI":"10.1186\/1475-2875-10-66"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Njama-Meya D, Kamya MR, Dorsey G (2004) Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children. Trop Med Int Health 9: 862\u2013868. 10.1111\/j.1365-3156.2004.01277.x [doi];TMI1277 [pii].","DOI":"10.1111\/j.1365-3156.2004.01277.x"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.2001.64.172","article-title":"Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia","volume":"64","author":"H Yoshimine","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, <etal>et al<\/etal>.. (2004) Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364: 1236\u20131243. S0140673604171407 [pii];10.1016\/S0140-6736(04)17140-7 [doi].","DOI":"10.1016\/S0140-6736(04)17140-7"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4269\/ajtmh.2003.68.68","article-title":"Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya","volume":"68","author":"FO ter Kuile","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4269\/ajtmh.2003.68.100","article-title":"Impact of permethrin-treated bed nets on malaria and all-cause morbidity in young children in an area of intense perennial malaria transmission in western Kenya: cross-sectional survey","volume":"68","author":"FO ter Kuile","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, <etal>et al<\/etal>.. (2004) Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364: 1428\u20131434. S0140673604172255 [pii];10.1016\/S0140-6736(04)17225-5 [doi].","DOI":"10.1016\/S0140-6736(04)17225-5"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, <etal>et al<\/etal>.. (1999) Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d&apos;Ivoire: a randomised controlled trial. Lancet 353: 1469\u20131475. S0140673699034650 [pii].","DOI":"10.1016\/S0140-6736(99)03465-0"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Zachariah R, Spielmann MP, Chinji C, Gomani P, Arendt V, <etal>et al<\/etal>.. (2003) Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS 17: 1053\u20131061. 10.1097\/01.aids.0000060355.78202.b7 [doi];00002030-200305020-00015 [pii].","DOI":"10.1097\/00002030-200305020-00015"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Badri M, Maartens G, Wood R, Ehrlich R (1999) Co-trimoxazole in HIV-1 infection. Lancet 354: 334\u2013335. S0140-6736(05)75237-5 [pii];10.1016\/S0140-6736(05)75237-5 [doi].","DOI":"10.1016\/S0140-6736(05)75237-5"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Anglaret X, Chene G, Attia A, Toure S, Lafont S, <etal>et al<\/etal>.. (1999) Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d&apos;Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 353: 1463\u20131468. S0140673698073991 [pii].","DOI":"10.1016\/S0140-6736(98)07399-1"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00002030-200106150-00009","article-title":"Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO\/UNAIDS recommendations","volume":"15","author":"M Badri","year":"2001","journal-title":"AIDS"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Mermin J, Lule J, Ekwaru JP, Downing R, Hughes P, <etal>et al<\/etal>.. (2005) Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. AIDS 19: 1035\u20131042. 00002030-200507010-00008 [pii].","DOI":"10.1097\/01.aids.0000174449.32756.c7"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Thera MA, Sehdev PS, Coulibaly D, Traore K, Garba MN, <etal>et al<\/etal>.. (2005) Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 192: 1823\u20131829. JID35552 [pii];10.1086\/498249 [doi].","DOI":"10.1086\/498249"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"d1617","DOI":"10.1136\/bmj.d1617","article-title":"Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial","volume":"342","author":"TG Sandison","year":"2011","journal-title":"BMJ"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Inion I, Mwanyumba F, Gaillard P, Chohan V, Verhofstede C, <etal>et al<\/etal>.. (2003) Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 188: 1675\u20131678. JID30728 [pii];10.1086\/379737 [doi].","DOI":"10.1086\/379737"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4269\/ajtmh.1998.59.813","article-title":"Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection","volume":"59","author":"ME Parise","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, <etal>et al<\/etal>.. (2006) Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 194: 286\u2013293. JID36018 [pii];10.1086\/505080 [doi].","DOI":"10.1086\/505080"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Peters PJ, Thigpen MC, Parise ME, Newman RD (2007) Safety and toxicity of sulfadoxine\/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Saf 30: 481\u2013501. 3063 [pii].","DOI":"10.2165\/00002018-200730060-00003"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Kapito-Tembo A, Meshnick SR, van Hensbroek MB, Phiri K, Fitzgerald M, <etal>et al<\/etal>.. (2011) Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. J Infect Dis 203: 464\u2013472. jiq072 [pii];10.1093\/infdis\/jiq072 [doi].","DOI":"10.1093\/infdis\/jiq072"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Siega-Riz AM, Savitz DA, Zeisel SH, Thorp JM, Herring A (2004) Second trimester folate status and preterm birth. Am J Obstet Gynecol 191: 1851\u20131857. S0002937804008609 [pii];10.1016\/j.ajog.2004.07.076 [doi].","DOI":"10.1016\/j.ajog.2004.07.076"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1177\/15648265080292S114","article-title":"Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development","volume":"29","author":"AM Molloy","year":"2008","journal-title":"Food Nutr Bull"},{"key":"ref78","first-page":"S3","article-title":"Folate and vitamin B12 deficiencies: proceedings of a WHO technical consultation held 18\u201321 October, 2005, in Geneva, Switzerland. Introduction","volume":"29","year":"2008","journal-title":"Food Nutr Bull"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1007\/BF01643198","article-title":"Hematological side effects of co-trimoxazole","volume":"15","author":"H Heimpel","year":"1987","journal-title":"Infection"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343: 1608\u20131614. 10.1056\/NEJM200011303432204 [doi].","DOI":"10.1056\/NEJM200011303432204"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/aje\/153.10.961","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy","volume":"153","author":"S Hernandez-Diaz","year":"2001","journal-title":"Am J Epidemiol"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 15: 637\u2013646. S0890623801001782 [pii].","DOI":"10.1016\/S0890-6238(01)00178-2"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Walter J, Mwiya M, Scott N, Kasonde P, Sinkala M, <etal>et al<\/etal>.. (2006) Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts. J Infect Dis 194: 1510\u20131518. JID36726 [pii];10.1086\/508996 [doi].","DOI":"10.1086\/508996"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Newman PM, Wanzira H, Tumwine G, Arinaitwe E, Waldman S, <etal>et al<\/etal>.. (2009) Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malar J 8: 254. 1475-2875-8-254 [pii];10.1186\/1475-2875-8-254 [doi].","DOI":"10.1186\/1475-2875-8-254"},{"key":"ref85","first-page":"24","article-title":"Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings","volume":"8","author":"F Forna","year":"2006","journal-title":"AIDS Rev"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Tomasulo P (2007) LactMed-new NLM database on drugs and lactation. Med Ref Serv Q 26: 51\u201358. 10.1300\/J115v26S01_04 [doi].","DOI":"10.1300\/J115v26S01_04"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Ho JM, Juurlink DN (2011) Considerations when prescribing trimethoprim-sulfamethoxazole. CMAJ 183: 1851\u20131858. cmaj.111152 [pii];10.1503\/cmaj.111152 [doi].","DOI":"10.1503\/cmaj.111152"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Santos F, Sheehy O, Perreault S, Ferreira E, Berard A (2011) Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study. BJOG 118: 1374\u20131382. 10.1111\/j.1471-0528.2011.03041.x [doi].","DOI":"10.1111\/j.1471-0528.2011.03041.x"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4269\/ajtmh.2003.69.247","article-title":"Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria","volume":"69","author":"D Kyabayinze","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Dorsey G, Dokomajilar C, Kiggundu M, Staedke SG, Kamya MR, <etal>et al<\/etal>.. (2004) Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. Am J Trop Med Hyg 71: 758\u2013763. 71\/6\/758 [pii].","DOI":"10.4269\/ajtmh.2004.71.758"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, <etal>et al<\/etal>.. (2002) Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 185: 380\u2013388. JID010620 [pii];10.1086\/338566 [doi].","DOI":"10.1086\/338566"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV (2001) Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 358: 1066\u20131067. S0140-6736(01)06201-8 [pii];10.1016\/S0140-6736(01)06201-8 [doi].","DOI":"10.1016\/S0140-6736(01)06201-8"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","article-title":"Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum","volume":"94","author":"T Triglia","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Gasasira AF, Kamya MR, Ochong EO, Vora N, Achan J, Charlebois E, <etal>et al<\/etal>.. (2010) Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malar J 9: 177. 1475-2875-9-177 [pii];10.1186\/1475-2875-9-177 [doi].","DOI":"10.1186\/1475-2875-9-177"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Malamba S, Sandison T, Lule J, Reingold A, Walker J, Dorsey G, <etal>et al<\/etal>.. (2010) Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus. Am J Trop Med Hyg 82: 766\u2013771. 82\/5\/766 [pii];10.4269\/ajtmh.2010.08-0408 [doi].","DOI":"10.4269\/ajtmh.2010.08-0408"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Malamba SS, Mermin J, Reingold A, Lule JR, Downing R, <etal>et al<\/etal>.. (2006) Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. Am J Trop Med Hyg 75: 375\u2013380. 75\/3\/375 [pii].","DOI":"10.4269\/ajtmh.2006.75.375"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, <etal>et al<\/etal>.. (2008) Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg 79: 320\u2013330. 79\/3\/320 [pii].","DOI":"10.4269\/ajtmh.2008.79.320"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0035-9203(87)90226-4","article-title":"In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination","volume":"81","author":"E Petersen","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Feikin DR, Dowell SF, Nwanyanwu OC, Klugman KP, Kazembe PN, <etal>et al<\/etal>.. (2000) Increased carriage of trimethoprim\/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine\/pyrimethamine. J Infect Dis 181: 1501\u20131505. JID991074 [pii];10.1086\/315382 [doi].","DOI":"10.1086\/315382"},{"key":"ref100","unstructured":"WHO (2010) WHO policy recommendation on IPTi."},{"key":"ref101","first-page":"63","article-title":"Cotrimoxazole, clinical uses and malaria chemotherapy","volume":"39","author":"FA Fehintola","year":"2010","journal-title":"Afr J Med Med Sci"},{"key":"ref102","unstructured":"Petri WA (2012) Sulfamethoxazole; Trimethoprim sulfamethoxazole, Quinoline and agents for Urinary Tract Infection. In: Brunton LL LJ, Parker KL, editors. Gilman and Goodman&apos;s The Pharmacological Basis of Therapeutics. McGraw-Hill."},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Farrell J, Naisbitt DJ, Drummond NS, Depta JP, Vilar FJ, <etal>et al<\/etal>.. (2003) Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J Pharmacol Exp Ther 306: 229\u2013237. 10.1124\/jpet.103.050112 [doi];jpet.103.050112 [pii].","DOI":"10.1124\/jpet.103.050112"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/AAC.39.12.2661","article-title":"Monitoring of co-trimoxazole concentrations in serum during treatment of pneumocystis carinii pneumonia","volume":"39","author":"B Joos","year":"1995","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0056916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T02:02:13Z","timestamp":1562724133000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0056916"}},"subtitle":[],"editor":[{"given":"Philip","family":"Bejon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,22]]},"references-count":104,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0056916","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,22]]}}}